Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KHC vs MRNA✓SelectedUSD · MRNAKHC vs MRNA performance historyLatest closeAs of+1.31%11/18
Stock and ETF performance explorer

KHC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+8.9%
MRNA return
+703.6%
Excess return
-694.7%
Maximum drawdown
-19.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.3%-4.8%+6.2%+1.4%
7D+4.8%-20.9%+25.7%+5.0%
30D+9.8%-13.3%+23.1%+9.8%
3M+4.1%+212.6%-208.4%+1.4%
6M+12.7%+309.0%-296.3%+12.0%
YTD+10.3%+567.3%-557.0%+11.5%
1Y+8.9%+689.7%-680.8%+9.6%
All+8.9%+703.6%-694.7%+9.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling